Table 4.

Incidence of febrile neutropenia and neutropenia over all cycles and in the first cycle according to intention of lipegfilgrastim treatment.

	All patients (N=228)	Primary prophylaxis (n=180)	Secondary prophylaxis (n=29)	Data missing (n=19)
All cycles, n	998	817	120	61
Febrile neutropenia, no. of patients (%)	6 (2.6)	3 (1.7)	2 (6.9)	1 (5.3)
Grade 3/4 neutropenia, no. of patients (%)	5 (2.2)	4 (2.2)	1 (3.4)	0
First cycles, n	228	180	29	19
Febrile neutropenia, no. of patients (%)	3 (1.3)	1 (0.6)	1 (3.4)	1 (5.3)
Grade 3/4 neutropenia, no. of patients (%)	2 (0.9)	2 (1.1)	0	0